Φορτώνει......
Immune checkpoint inhibitors in small cell lung cancer
Small cell lung cancer (SCLC) is a rapidly progressive cancer that often debilitates patients within months of detection and quickly becomes refractory to the limited options of therapy. While SCLC is not generally considered an immunogenic tumor, clinical experience suggests that patients with robu...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Thorac Dis |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861263/ https://ncbi.nlm.nih.gov/pubmed/29593891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.51 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|